Anavex Life Sciences Corp (AVXL)

[jimmy667]

Almost unheard of. " Running trials for many indications with one drug. BLA has been submitted in HIV for combo therapy and trials are running for HIV mono therapy, 22 solid tumor cancers, Covid19 and planning trials in MS and ALZ with one drug. Leronlimab one of the few potentially effective mAbs with little or no side effects. Safety profile on par with blarcamesine, chosen trade names Vyrologic for HIV and Immunovance for Immunologic diseases.
If a combo therapy is needed for ALZ the dream combination MIGHT be the two flexible broad application drugs with the best safety record in the highly susceptible and fragile patient groups. Blarcamesine for cellular homeostasis and leronlimab for the immune response and inflammation.
Together those two drugs could potentially dominate the market for the biggest cash generators of both Biogen and Gilead as well as a huge cancer market. Lets not forget the preclinical studies of Anavex SigmaCeptor (tm) Platform drugs for cancer and neuropathic pain. (Lyrica?)
Together blarcamesine and leronlimab might make music together like Lennon and McCartney. Both are close to their first approvals.
No matter what the shorts feel about the companies developing blarcamesine and leronlimab both of these drugs are proven safe and are being pushed forward in many indications some of which already overlap. The drugs and the science will prevail and possiblity these drugs together might make music that will change the World.